Identifying Maturity-onset Diabetes of the Young in Emirati Patients
Maturity-onset Diabetes of the Young, Monogenic Diabetes, MODY
About this trial
This is an interventional diagnostic trial for Maturity-onset Diabetes of the Young focused on measuring Maturity-onset Diabetes of the Young (MODY), Diabetes Mellitus, Diagnosis, Precision Medicine
Eligibility Criteria
Inclusion Criteria:
- Age > 11; both male or female, Emirati patients only
- Diagnosed to have Type 1 or Type 2 Diabetes Mellitus diagnosed before the age of 40 and after the age of 6 months.
- Attended Tawam hospital during the last 1 year.
- All previous antibodies testing being negative.
- Absence of ketoacidosis / significant ketosis in the past medical records
Exclusion Criteria:
- BMI of 40 or above (class 3 / severe obesity)
- History of Secondary diabetes (e.g. Diabetes following pancreatitis)
- Absent/Decreased C-peptide activity suggestive of Type 1 Diabetes
Sites / Locations
Arms of the Study
Arm 1
Other
patients labelled as Type 1 or Type 2 Diabetes
paediatric or adult patients already diagnosed with either type 1 or type 2 diabetes mellitus, following up with Tawam Hospital Diabetes clinics for at least 1 year, (who have negative autoimmunity, lack of significant ketosis and either family history of diabetes in one parent or BMI<40). Patient with age > 11; both male or female, Emirati patients only, who attended Diabetes clinic Tawam hospital during the last 1 year AND Diagnosed to have Type 1 or Type 2 Diabetes Mellitus diagnosed before the age of 40 and after the age of 6 months (to exclude neonatal diabetes). • .